These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26745109)

  • 1. Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells.
    Gajek A; Denel-Bobrowska M; Rogalska A; Bukowska B; Maszewski J; Marczak A
    Asian Pac J Cancer Prev; 2015; 16(18):8503-12. PubMed ID: 26745109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line.
    Gajek A; Denel M; Bukowska B; Rogalska A; Marczak A
    Toxicol In Vitro; 2014 Mar; 28(2):273-81. PubMed ID: 24287111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
    Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
    Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.
    Denel-Bobrowska M; Lukawska M; Oszczapowicz I; Marczak A
    Asian Pac J Cancer Prev; 2016; 17(9):4223-4231. PubMed ID: 27797222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells.
    Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspases and ROS - dependent mechanism of action mediated by combination of WP 631 and epothilone B.
    Rogalska A; Bukowska B; Marczak A
    Anticancer Agents Med Chem; 2014; 14(9):1261-70. PubMed ID: 24913659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines.
    Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
    Chem Biol Interact; 2014 Sep; 220():140-8. PubMed ID: 24998637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells.
    Marczak A; Bukowska B; Rogalska A
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):256-66. PubMed ID: 24374386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
    Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
    Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why a Combination of WP 631 and Epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage.
    Bukowska B; Rogalska A; Forma E; Brys M; Marczak A
    Asian Pac J Cancer Prev; 2016; 17(3):1299-308. PubMed ID: 27039763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Toxicol In Vitro; 2014 Jun; 28(4):675-83. PubMed ID: 24583341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway.
    Malugin A; Kopecková P; Kopecek J
    Mol Pharm; 2004; 1(3):174-82. PubMed ID: 15981920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells.
    Chua CC; Liu X; Gao J; Hamdy RC; Chua BH
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2606-13. PubMed ID: 16687611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleistopholine isolated from Enicosanthellum pulchrum exhibits apoptogenic properties in human ovarian cancer cells.
    Nordin N; Majid NA; Mohan S; Dehghan F; Karimian H; Rahman MA; Ali HM; Hashim NM
    Phytomedicine; 2016 Apr; 23(4):406-16. PubMed ID: 27002411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    J Control Release; 2001 Apr; 71(3):227-37. PubMed ID: 11295216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. δ-Cadinene inhibits the growth of ovarian cancer cells via caspase-dependent apoptosis and cell cycle arrest.
    Hui LM; Zhao GD; Zhao JJ
    Int J Clin Exp Pathol; 2015; 8(6):6046-56. PubMed ID: 26261482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.
    Bae SN; Lee YS; Kim MY; Kim JD; Park LO
    Gynecol Oncol; 2006 Oct; 103(1):127-36. PubMed ID: 16624386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
    Kim BM; Choi YJ; Lee YH; Joe YA; Hong SH
    Apoptosis; 2010 Aug; 15(8):982-93. PubMed ID: 20512627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.